Bifogade filer
Kurs
+2,47%
Likviditet
0,74 MSEK
Kalender
Tid* | ||
2025-06-03 | 07:00 | Bokslutskommuniké 2025 |
2025-03-03 | 07:00 | Kvartalsrapport 2025-Q3 |
2024-12-04 | - | Kvartalsrapport 2025-Q2 |
2024-09-26 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2024-09-25 | - | Årsstämma |
2024-08-29 | - | Kvartalsrapport 2025-Q1 |
2024-05-30 | - | Bokslutskommuniké 2024 |
2024-02-29 | - | Kvartalsrapport 2024-Q3 |
2023-12-04 | - | Kvartalsrapport 2024-Q2 |
2023-10-04 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2023-09-27 | - | Årsstämma |
2023-08-31 | - | Kvartalsrapport 2024-Q1 |
2023-06-08 | - | Bokslutskommuniké 2023 |
2023-03-01 | - | Kvartalsrapport 2023-Q3 |
2022-12-01 | - | Kvartalsrapport 2023-Q2 |
2022-10-03 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2022-09-28 | - | Årsstämma |
2022-08-31 | - | Kvartalsrapport 2023-Q1 |
2022-06-10 | - | Bokslutskommuniké 2022 |
2022-03-02 | - | Kvartalsrapport 2022-Q3 |
2021-12-02 | - | Kvartalsrapport 2022-Q2 |
2021-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2021-09-02 | - | Kvartalsrapport 2022-Q1 |
2021-05-31 | - | Bokslutskommuniké 2021 |
2021-03-03 | - | Kvartalsrapport 2021-Q3 |
2020-12-02 | - | Kvartalsrapport 2021-Q2 |
2020-09-30 | - | Årsstämma |
2020-09-09 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2020-08-24 | - | Kvartalsrapport 2021-Q1 |
2020-06-08 | - | Bokslutskommuniké 2020 |
2020-04-20 | - | Extra Bolagsstämma 2020 |
2020-03-02 | - | Kvartalsrapport 2020-Q3 |
2019-12-02 | - | Kvartalsrapport 2020-Q2 |
2019-09-30 | - | Årsstämma |
2019-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2019-09-02 | - | Kvartalsrapport 2020-Q1 |
2019-06-10 | - | Bokslutskommuniké 2019 |
2019-03-04 | - | Kvartalsrapport 2019-Q3 |
2018-12-17 | - | Kvartalsrapport 2019-Q2 |
2018-09-25 | - | X-dag ordinarie utdelning INTEG B 0.00 SEK |
2018-09-24 | - | Årsstämma |
2018-09-24 | - | Kvartalsrapport 2019-Q1 |
2018-06-25 | - | Bokslutskommuniké 2018 |
2018-03-26 | - | Kvartalsrapport 2018-Q3 |
2017-12-18 | - | Kvartalsrapport 2018-Q2 |
2017-09-25 | - | Årsstämma |
2017-09-25 | - | Kvartalsrapport 2018-Q1 |
2017-06-30 | - | Bokslutskommuniké 2017 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Mölndal, Sweden, September 27, 2023 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is attending an international meeting and workshop event gathering experts in the field of osseointegration and bionic limb reconstruction, at the prestigious Rizzoli Orthopaedic Institute at the University of Bologna, Italy, on October 18-19[th].
Integrum AB is the main sponsor for the International Workshop (https://www.ior.it/en/archivio-eventi/international-workshop-osseointegration-and-bionic-limb-reconstruction) on Osseointegration and Bionic Limb Reconstruction at the prestigious Rizzoli Orthopaedic Institute in Bologna, October 18[th]-19[th] 2023.
The meeting will gather a select group of global pioneering experts, working in medicine and bioengineering to further the field of limb reconstruction. The overarching aim of the event is to share new insights and knowledge to develop clinical solutions that improve the function and quality of life for individuals living with an amputated limb today, and tomorrow.
"I look forward to taking part in the latest discussions concerning the development of limb reconstruction techniques based on osseointegration and bionics. To maintain our position as one of the leading companies in the field, it is important to continuously communicate our insights, gained from applying our solutions in patients, and fortify our connections with the forefront of academic and clinical researchers and experts" comments Rickard Brånemark, CEO of Integrum.
The Rizzoli Orthopaedics Institute is the main institute of orthopaedics and traumatology in Italy. With about 150,000 patients examined each year and 18,000 orthopaedic operations, it also has strong scientific research which is carried out in their 9 laboratories. The Rizzoli Orthopaedics Institute is one of the most prestigious hospitals in the world and was recently ranked the number 5 orthopaedic hospital in the world by Newsweek (https://www.newsweek.com/rankings/worlds-best-specialized-hospitals-2023/orthopedics).
Rickard Brånemark, CEO. Phone: +46 708 461061, E-mail: rickard.branemark@integrum.se
Jörgen Svanström, CFO. Phone: +46 (0) 70 734 96 60, E-mail: jorgen.svanstrom@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser.